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The development of endonuclease-mediated genome editing technologies, in particular CRISPR/Cas9, has revolutionized mouse genetics by opening up the possibility to bypass the long and labor intensive embryonic stem cell-based methods and achieve precise genome editing directly in zygote stage embryos 1 .
CRISPR/Cas9-mediated genome editing has shown consistently high efficiency in generating indels, point mutations and small insertions in zygotes 2, 3 , largely making use of the non-homologous end-joining (NHEJ) and homology directed repair (HDR) pathways. However, the efficiency of precise introduction of large fragments by homologous recombination (HR) is still not ideal 4, 5 . Previous reports have suggested methods to increase large fragment knock-in efficiency in zygotes, by Cas9-RNP injection 6 , with templates activating micro-homology mediated end joining or long-homology mediated end joining pathways 4, 7 , with long singlestranded DNA templates or by chemically manipulating DNA repair pathways 8, 9 .
However, only a limited number of successfully targeted loci have been reported to date 4 . Some methods produce imprecise junctions at editing sites 7 , while others are limited by practical considerations and the size of the DNA fragment that can be inserted (up to 2 kb) 8 .
Fluorescent reporter mouse lines, which allow for direct visualization and live imaging of molecular and cellular dynamics during developmental, regenerative and pathological processes are among the most commonly generated models using large fragment knock-in. The preimplantation mouse embryo is an ideal model to study basic developmental mechanisms by live imaging 10 . Two consecutive crucial cell fate decisions separate embryonic and extraembryonic lineages and define three cell types in a 4-day time frame 10 . Moreover, because of the highly accessible nature of preimplantation embryos, they serve as excellent models to develop and apply cutting edge imaging and gene manipulation techniques such as single molecule tracking 11 , optogenetics and induced protein degradation systems 12, 13 .
Considering these advantages, we set out to generate a series of reporter mouse lines to study preimplantation development in embryos. The inconsistent and relatively low efficiency of knock-in reporter allele generation became a major hurdle and necessitated the development of methods for improved large fragment insertion in the mouse germ line.
HR is predominantly active in late S/G2 phases of the cell cycle 14 . It has been shown that timely delivery of Cas9-RNP and donor DNA into G2-synchronised cells or restricting the presence of Cas9 protein to late S/G2 phases by fusing it with Geminin in vitro significantly increased knock-in efficiency [15] [16] [17] . Approaching the problem from a mouse developmental biologist's perspective, we reasoned that the 2-cell stage might be an ideal window for introducing large DNA fragments by HR, as the G2 phase during this cell cycle is exceptionally long (10-12 hours) and is relatively synchronized between developing embryos. Additionally, major zygotic genome activation, which takes place during the extended G2 phase of the 2-cell stage, is associated with an open chromatin state and would thus likely increase the accessibility of the chromatin to editing enzymes and repair templates (Fig. 1a) . We therefore set out to generate large fragment knock-in alleles in mouse embryos by injecting CRISPR/Cas9 reagents and repair templates into 2-cell embryos (2C-HR-CRISPR). We first compared the knock-in efficiencies at the 2-cell and zygote stages by generating two reporter alleles: a) the fusion of a minimum auxin degron (mAID) domain 18 and mCherry to the C-terminus of Sox2 (Sox2-mAID-mCherry)(with 5 and 1 kb homology arms) and b) the fusion of the Halo-tag 19 to the C-terminus of Gata6 (with 2 and 3 kb homology arms) (Fig. 1b) . We microinjected Cas9 mRNA, sgRNA and a circular donor plasmid into the cytoplasm of either zygotes or both cells of 2-cell embryos (Supplementary Movie 1). As both genes have highly specific expression patterns in the blastocyst, we evaluated targeting efficiencies by culturing microinjected embryos to the blastocyst stage and scoring for the presence and localization of the fluorescent tag by both live imaging and coimmunostaining with lineage markers (Supplementary Fig. 1 ). The knock-in efficiency increased from less than 1% with zygote microinjection to 31.5% with 2-cell microinjection for Sox2-mAID-mCherry and from 6.5% to 35% for Gata6-Halo (Fig. 1b) . We noted mosaicism in targeted embryos ( Supplementary Fig. 2 ), similar to observations in founder animals generated by CRISPR-editing in zygotes. This is likely due to varied independent editing of alleles in S/G2 phase zygotes (4 alleles for most genes) and G2 phase 2-cell embryos (8 alleles for most genes). While the increase in allele numbers at the 2-cell stage may partly contribute to the increased knock-in efficiency, CRISPR-mediated gene editing at 2-cell stage increased knock-in efficiency well beyond 2-fold, demonstrating a real increase in targeting efficiency per allele by 2-cell microinjection.
To demonstrate the wider applicability of the 2C-HR-CRISPR method, we generated reporter alleles (with up to 4.5 kb insert size) for 20 loci in the mouse genome (Fig. 1c) . We mostly constructed C or N-terminal fusions or in some cases using the self-cleaving T2A peptide 20 (T2A-H2B-reporter) with different reporter tags such as GFP, mCherry, Halo 19 and miRFP703 21 . We selected most "classical" lineage markers covering all three cell types of the blastocyst. These included epibalst (EPI) (Sox2, Nanog, Oct4 and Esrrb), primitive endoderm (PE) (Gata6, Gata4, Sox17, Fgfr2 and Pdgfra) and trophectoderm (TE) (Cdx2, Eomes and Gata3) markers 10 (Fig. 1c) . We also targeted Id2 and Dppa1, two genes which have so far only been predicted to be TE-specific lineage markers based on mRNA profiles 22,23 .
Additionally, we selected a number of other genes, including the chromatin structural regulator Ctcf, the transcriptional elongation factor Cdk9, the cell signaling kinase Mapk1 (Erk2) and two safe-harbor loci where insertion of transgenes provides high and uniform expression in all cells (the Rosa26 (R26) 24 and the beta-Actin (Actb) loci). Importantly, we succeeded in targeting all 20 selected loci, as read out by correct lineage and subcellular localization of the tag in microinjected embryos cultured to the blastocyst stage and validated correct targeting either by PCR genotyping single embryos or by immunostaining targeted blastocysts where antibodies against the endogenous protein were available ( Supplementary Fig. 1 ). We found that targeting showed a highly reproducible locus and sgRNA-dependent efficiency ( Fig. 1c and Supplementary Fig. 3 ). However, we did not find any loci that we could not target. Overall knock-in efficiency varied between 11-55% depending on the locus. Additionally, we showed that targeting efficiencies were comparable on an outbred or inbred (C57Bl/6J) mouse background ( Supplementary Fig. 4 ). Therefore, we demonstrated that 2C-HR-CRISPR is a highly robust method to generate large fragment knock-in alleles.
Apart from the activity of HR pathway, the availability of the repair template could be another limiting factor for knock-in generation. Methods to recruit the repair template to the editing site have been explored to improve targeting efficiencies 25, 26 . We therefore constructed a fusion gene between Cas9 and monomeric streptavidin (Cas9-mSA) 27 and generated biotinylated repair templates containing homology arms and insertion fragments by PCR amplification (BIO-PCR) from targeting vectors with 5'-biotinylated primers (Fig. 1d) . Using this Cas9-mSA/BIO-PCR method we further improved targeting efficiencies at each of the 5 genes tested (Fig. 1e) , reaching an extreme of 95% knock-in efficiency when targeting a Halo-tag to the C-terminus of Gata6. We also observed an increase in the number of fluorescently labeled cells in individual embryos, suggesting an increase in the number of alleles correctly targeted and consequently a likely decrease in mosaicism. Moreover, from two out of the three male Gata6-Halo founder mice generated using the Cas9-mSA/BIO-PCR method (see later) we obtained 100% Gata6-Halo positive blastocysts by breeding to CD1 females suggesting that all germ cell progenitors were homozygously targeted.
We then transferred microinjected embryos to generate reporter mouse lines (Fig. 2a) . These included three reporter lines for preimplantation cell lineages: Sox2-mAID-mCherry and Nanog-mAID-mCherry for the EPI lineage and Gata6-Halo for the PE lineage, a Cdk9-Halo line for imaging transcription dynamics in early embryos, and a far red pan-nuclear marker line R26-CAG-H2B-miRFP703. We successfully obtained positive founder animals from all transfer sessions and validated correct targeting by long-range genotyping PCR. Importantly, we obtained germ line transmission from all founders tested by both visualizing the correct localization of reporters in N1 generation blastocysts (Fig. 2b) and genotyping N1 animals.
Furthermore, we validated the correct sequence of the knock-in allele in N1 animals by Sanger sequencing the 5' and 3' junctions of the insertion, including the homology arms (data not shown) and excluded the possibility of random integrations and concatemer insertions by digital droplet PRC. We did not rule out the possibility of off-target effects, however, as outcrossing is necessary to deplete incorrectly edited alleles, other byproducts of CRISPR-mediated editing will also be bred out during mouse line production and thus do not pose a threat. Moreover, as 2C-HR-CRISPR does not involve any manipulation of the cell cycle or DNA-repair pathways, as attempted in other previous studies, the likelihood of undesirable genomic perturbations is minimal.
By breeding 2C-HR-CRISPR-generated mouse lines (Nanog-mAID-mCherry and Gata6-Halo) to an existing Cdx2-eGFP reporter line 28 we were able to produce the first live triple-color blastocysts, in which all cells were marked by a reporter in a lineage dependent manner (Fig. 2c) . Multi-color reporter embryos will be invaluable tools for exploring lineage segregation in real time by live imaging and resolving long-standing controversies stemming from attempts to reconstruct dynamic developmental processes from static snapshots. As proof of principle, we followed the development of Cdx2-eGFP/Gata6-Halo embryos (1 Z-stack/hour) for 30 hours from the 16-cell to the blastocyst stage by live imaging (Supplementary Given the high frequency of targeting by 2C-HR-CRISPR, we attempted to achieve double targeting in embryos by simultaneously tagging Nanog with mAIDmCherry using the Cas9-mSA/BIO-PCR method and Gata6 with the Halo-Tag using the Cas9/plasmid method. Efficient (29%) precise insertion of both large fragments in the same embryo was achieved ( Fig. 3a and b) . We then tested the delivery and the applicability of the auxin-inducible degron system in embryos, a two-component tool for inducible, rapid and reversible protein degradation (Fig. 3c) , which has so far only been utilized in yeast 13 , C. elegans 31 or mammalian cell culture systems 18 .
We simultaneously targeted TIR1-GFP to the Actb locus (Actb-T2A-TIR1-GFP) and
Halo-mAID to the C-terminus of Gata6 (Gata6-Halo-mAID) or mAID-mCherry to the C-terminus of Sox2 and identified blastocysts with double-targeted cells. TIR1, a plant-specific F-box protein recruits the SCF ubiquitin ligase complex 18 to mAIDtagged proteins in an auxin (IAA)-dependent manner, which results in their polyubiquitination and subsequent proteasome-mediated degradation. Following addition of IAA to embryos with double-targeted cells we found that in TIR1-GFP positive cells, Gata6-Halo-mAID was depleted to background levels in 30-60 minutes and Sox2-mAID-mCherry was degraded in 30-80 min, while in TIR1-GFP negative cells expression of the reporters remained stable (Fig 3d and Supplementary Fig. 6 ).
We then washed out IAA and traced the recovery of proteins for 2-3 hours. We found that both Gata6-Halo-mAID and Sox2-mAID-mCherry gradually re-appeared in TIR1-GFP positive cells within this time frame. Additionally, we confirmed that culturing preimplantation embryos in the presence of IAA had no adverse effect on development (data not shown). We thus demonstrate for the first time the use of the auxin-inducible degron system in mouse embryos for inducible and reversible degradation of endogenous proteins.
In summary, 2C-HR-CRISPR is a robust method to insert any large fragment in a site-specific manner into the mouse genome, accelerating transgenic knock-in mouse production. In addition to targeting endogenous genes, 2C-HR-CRISPR can be used to insert transgenes at defined 'safe harbor' sites, thus avoiding position effects that accompany standard trangenesis and can facilitate the application of synthetic biology tools in mouse models.
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Methods
Mouse lines and embryos
CD1(ICR) (Charles River), C57Bl/6J (Charles River) and Cdx2-eGFP (knock-in fusion to endogenous locus) 1 mouse lines were used as embryo donors in this study.
Embryos were collected from superovulated and mated females as described before 2 . Zygotes were isolated from the oviduct at 0.5 days post coitum (dpc) and washed clean of cumulus cells by brief treatment with 300μg/ml hyaluronidase (Sigma). 2-cell embryos were collected at 1.5 dpc and blastocysts at 3.5 dpc. If not immediately used, embryos were cultured in small drops of KSOM supplemented with amino acids (EMD Milipore) under mineral oil (Zenith Biotech) at 37°C, with 6% CO 2 for specified times. Oligos DNA oligos were synthesized by either Sigma or IDT and all sequences used in this study are provided in Supplementary Table 1 .
Constructs
To construct pCS2+-Cas9-mSA, the mSA coding sequence was amplified from pDisplay-mSA-EGFP-TM (a gift from Dr. Sheldon Park (Addgene plasmid #39863)) 3 and fused to the C-terminus of the Cas9 coding sequence with an optimized linker 4 in pCS2+-Cas9 using InFusion cloning. sgRNAs with predicted off-target sites in coding regions were excluded. sgRNA cloning into pX330 vectors (a kind gift from Dr. Feng Zhang (Addgene plasmid #42230)) was performed as previously described 9 .
EasyFusion donor vectors for rapid cloning of knock-in targeting constructs
To 
RNA synthesis
RNAs were synthesized as described before 2 . Briefly, to produce Cas9 or Cas9-mSA mRNA, the pCS2+-Cas9 or pCS2+-Cas9-mSA plasmid was linearized with NotI restriction digestion and used as template for in vitro transcription using the mMESSAGE mMACHINE® SP6 Transcription Kit (Thermo Fisher Scientific). For the production of sgRNAs, sgRNA coding sequences were PCR-amplified from the pX330 plasmids with primers containing the T7 promoter and used as template to produce sgRNA using the MEGAshortscript™ T7 Transcription Kit (Thermo Fisher Scientific).
All RNA products were purified using the RNeasy Mini Kit (Qiagen) following the clean-up protocol.
Cytoplasmic microinjection of zygote and 2-cell stage embryos
Cytoplasmic microinjection of zygotes and 2-cell stage embryos were performed as described previously 10 . Briefly, Cas9 mRNA (100ng/μl) or Cas9-mSA mRNA (75ng/μl), sgRNA (50ng/μl) and donor plasmids (30ng/μl) or BIO-PCR donors (20ng/μl) were microinjected in nuclease-free injection buffer (10mM Tris-HCl, pH 7.4, 0.25mM EDTA). Microinjection was performed using a Leica microscope and micromanipulators (Leica Microsystems Inc). Injection pressure was provided by a FemtoJet (Eppendorf) and negative capacitance was generated using a Cyto721 11 .
Whole-mount immunofluorescent staining of embryos
Whole mount immunofluorescent staining of embryos was performed as previously 
Single blastocyst genotyping
Single blastocyst genotyping was performed as previously described 12 . Briefly, microinjected embryos cultured to the blastocyst stage were imaged on a spinning disk confocal microscope to evaluate targeting. Genomic DNA of single blastocysts was extracted with Red Extract-N-Amp kit (Sigma) and PCR genotyping was performed with gene-specific primers using PhireII polymerase (Thermo Fisher).
Confocal microscopy and image analysis
Both live and immunostained images were acquired using a Zeiss Axiovert 200 inverted microscope equipped with a Hamamatsu C9100-13 EM-CCD camera, a Quorum spinning disk confocal scan head and Volocity acquisition software version 6.3.1. Single plane images or Z-stacks (at 1μm intervals) were acquired with a 40x air (NA=0.6) or a 20x air (NA=0.7) objective. Images were analyzed using Volocity. 
Statistical analysis
No statistical methods were used to pre-determine sample size. The experiments were not blinded from investigators: the identities of the samples were known throughout the experiment. No statistical tests were performed in this study. 
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Supplementary Movie 1.
Cytoplasmic microinjections of 2-cell stage mouse embryos.
Supplementary Movie 2.
Live imaging Cdx2-eGFP/Gata6-Halo embryos from the 16-cell to blastocyst stage. Halo-Erk2 single embryo genotyping PCR 
